The Canadian pyschedelics company MagicMed will be taken over by the US firm Enveric Biosciences in a move that will create greater research and development as well as commercialisation opportunities
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.